These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3571382)

  • 21. Changes in hypothalamic neurotensin concentrations and food intake in rats fed a high fat diet.
    Beck B; Stricker-Krongrad A; Burlet A; Nicolas JP; Burlet C
    Int J Obes Relat Metab Disord; 1992 May; 16(5):361-6. PubMed ID: 1319971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between lower esophageal sphincter (LES) pressure and the plasma concentration of neurotensin during intravenous infusion of neurotensin(1-13) and (Gln4)neurotensin(1-13) in man.
    Theodorsson-Norheim E; Thor K; Rosell S
    Acta Physiol Scand Suppl; 1983; 515():29-35. PubMed ID: 6578671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A radioimmunoassay for neurotensin in human plasma.
    Shulkes A; Chick P; Wong H; Walsh JH
    Clin Chim Acta; 1982 Oct; 125(1):49-58. PubMed ID: 7139948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of plasma neurotensin during lipid perfusion of rat small intestine.
    Ferris CF; Hammer RA; Leeman SE
    Peptides; 1981; 2 Suppl 2():263-6. PubMed ID: 7343961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of neurotensin in gastroplasty for morbid obesity.
    Miskowiak J; Pedersen JH; Andersen B; Stadil F
    Regul Pept; 1984 Nov; 9(4):263-9. PubMed ID: 6522643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of neurotensin in the uptake and distribution of fat.
    Rosell S
    Ann N Y Acad Sci; 1982; 400():183-97. PubMed ID: 6963111
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolism of neurotensin and pancreatic polypeptide in man: role of the kidney and plasma factors.
    Shulkes A; Bijaphala S; Dawborn JK; Fletcher DR; Hardy KJ
    J Clin Endocrinol Metab; 1984 May; 58(5):873-9. PubMed ID: 6707191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone reduces fat-induced release of neurotensin in the rat.
    Theodorsson-Norheim E; Rosell S; Brattsand R
    Acta Physiol Scand; 1985 Mar; 123(3):331-3. PubMed ID: 4061114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radioimmunoassay of plasma neurotensin and clinical application].
    Matsumura M; Ono M; Mori H; Saito S
    Horumon To Rinsho; 1983 Jun; 31(6):531-4. PubMed ID: 6883768
    [No Abstract]   [Full Text] [Related]  

  • 30. The characterization and regional distribution of neuromedin N-like immunoreactivity in rat brain using a highly sensitive and specific radioimmunoassay. Comparison with the distribution of neurotensin.
    de Nadai F; Cuber JC; Kitabgi P
    Brain Res; 1989 Oct; 500(1-2):193-8. PubMed ID: 2605491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bile inhibits release of cholecystokinin and neurotensin.
    Gomez G; Lluis F; Guo YS; Greeley GH; Townsend CM; Thompson JC
    Surgery; 1986 Aug; 100(2):363-8. PubMed ID: 3738760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of gastric acid secretion by neurotensin in man. Evidence against a hormonal role.
    Mogard MH; Maxwell V; Sytnik B; Walsh JH
    J Clin Invest; 1987 Oct; 80(4):1064-7. PubMed ID: 3654970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased plasma neurotensin concentrations in patients with Parkinson's disease.
    Schimpff RM; Avard C; Fénelon G; Lhiaubet AM; Tennezé L; Vidailhet M; Rostène W
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):784-6. PubMed ID: 11385014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunoreactive neurotensin in children with gastrointestinal diseases].
    Teufel M; Niessen KH
    Monatsschr Kinderheilkd; 1986 Feb; 134(2):96-101. PubMed ID: 3702882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentration of neurotensin in human plasma after glucose, meals and lipids.
    Flaten O; Hanssen LE
    Acta Physiol Scand; 1982 Feb; 114(2):311-3. PubMed ID: 7136762
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of neurotensin-like immunoreactivity in human cerebrospinal fluid by high-performance liquid chromatography combined with mass spectrometry.
    Eriksson U; Andrén P; Silberring J; Nyberg F; Wiesel FA
    Biol Mass Spectrom; 1994 Apr; 23(4):225-9. PubMed ID: 8172930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromatographic and immunochemical characterization of neurotensin in cat adrenal gland and its release during splanchnic nerve stimulation.
    Ferris CF; Carraway RE; Brandt K; Leeman SE
    Neuroendocrinology; 1986; 43(3):352-8. PubMed ID: 3736783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organ and plasma metabolism of neurotensin in sheep.
    Shulkes A; Fletcher DR; Hardy KJ
    Am J Physiol; 1983 Nov; 245(5 Pt 1):E457-62. PubMed ID: 6638173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of immunosuppression and syngeneic and allogeneic small bowel transplantation on the fat-stimulated release of cholecystokinin and neurotensin in rats.
    Schlemminger R; Gieseler RK; Schleef J; Nustede R; Köhler H; Schafmayer A
    Transplant Proc; 1994 Jun; 26(3):1673-4. PubMed ID: 8030083
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurotensin in plasma: immunochemical and chromatographic character of acid/acetone-soluble material.
    Carraway R; Hammer RA; Leeman SE
    Endocrinology; 1980 Aug; 107(2):400-6. PubMed ID: 7389661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.